Lan K, Li S, Jia G, Li S, et al. Correction: Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma. Br J Cancer 2025 Aug 27. doi: 10.1038/s41416-025-03077.
PMID: 40866613